Molecular epidemiology of human coxsackievirus A16 strains.

Wenmin Yu, Huanxin Xu, Changchang Yin
Author Information
  1. Wenmin Yu: The School of Basic Medical Science, Jiujiang University/Key Laboratory of Translational Medicine, Jiujiang, Jiangxi 332000, P.R. China.
  2. Huanxin Xu: The Third People's Hospital of Jiujiang, Jiujiang, Jiangxi 332000, P.R. China.
  3. Changchang Yin: The School of Basic Medical Science, Jiujiang University/Key Laboratory of Translational Medicine, Jiujiang, Jiangxi 332000, P.R. China.

Abstract

The hand, foot and mouth disease (HFMD) epidemics have mainly been caused by human enterovirus 71 and human coxsackievirus A16 (CA16), which circulated alternatively or together in the epidemic area. The aim of the present study was to provide guidance in the prevention and control of HFMD from CA16 infection. The molecular epidemiology of the human CA16 strains was investigated. Overall, 1,151 specimens (throat swabs) were collected from 1,151 patients with HFMD symptoms. The results of the homology comparison in the VP1 of CA16 strains showed that the CA16 strains belonged to the B1b subgenotype. The difference of the 6 CA16 strains analyzed showed that the most prominent strain was the A genotype, and the most close strains were the B1 gene subtype, particularly the B1b gene subtype. With regards to the amino acids, in addition to the A genotype, the differences of amino acids with other gene subtype was not significant. The present data suggest that more effective and highly targeted intervention mechanisms could be developed for the prevention and control of HFMD.

Keywords

References

  1. J Virol. 2012 Nov;86(22):11967-76 [PMID: 22951825]
  2. Emerg Microbes Infect. 2015 Feb;4(2):e12 [PMID: 26038764]
  3. Emerg Infect Dis. 2003 Mar;9(3):291-3 [PMID: 12643822]
  4. Emerg Infect Dis. 2007 Jul;13(7):1084-6 [PMID: 18214187]
  5. J Gen Virol. 2004 Jun;85(Pt 6):1597-607 [PMID: 15166444]
  6. Zhonghua Liu Xing Bing Xue Za Zhi. 2010 Aug;31(8):904-8 [PMID: 21162993]
  7. J Virol. 1999 Mar;73(3):1941-8 [PMID: 9971773]
  8. Ann Acad Med Singapore. 2009 Feb;38(2):106-12 [PMID: 19271036]
  9. Commun Dis Rep CDR Rev. 1996 May 24;6(6):R81-6 [PMID: 8664928]
  10. J Clin Microbiol. 2007 Jan;45(1):112-20 [PMID: 17093028]
  11. Zhongguo Yi Miao He Mian Yi. 2009 Apr;15(2):135-40 [PMID: 20077659]
  12. PLoS One. 2015 Sep 23;10(9):e0138514 [PMID: 26398767]
  13. Emerg Infect Dis. 2009 Oct;15(10):1689-91 [PMID: 19861078]
  14. J Clin Microbiol. 2005 Aug;43(8):3835-9 [PMID: 16081920]
  15. Jpn J Infect Dis. 2009 Jul;62(4):254-9 [PMID: 19628900]
  16. Pediatr Infect Dis J. 2004 Mar;23(3):275-6 [PMID: 15014311]
  17. Lancet. 2012 Dec 1;380(9857):1946-55 [PMID: 23200503]
  18. Pediatr Infect Dis J. 1999 Dec;18(12):1092-6 [PMID: 10608631]
  19. J Clin Microbiol. 2010 Feb;48(2):619-22 [PMID: 20018819]

Word Cloud

Created with Highcharts 10.0.0CA16strainshumanHFMDcoxsackievirusA16epidemiologygenesubtypehandfootmouthdiseasepresentpreventioncontrolmolecular1151showedB1bgenotypeaminoacidsepidemicsmainlycausedenterovirus71circulatedalternativelytogetherepidemicareaaimstudyprovideguidanceinfectioninvestigatedOverallspecimensthroatswabscollectedpatientssymptomsresultshomologycomparisonVP1belongedsubgenotypedifference6analyzedprominentstraincloseB1particularlyregardsadditiondifferencessignificantdatasuggesteffectivehighlytargetedinterventionmechanismsdevelopedMolecularJiujiangregion

Similar Articles

Cited By